Fundz

In Situ Biologics reported raising $3 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEDec 29, 2023

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Dec 15, 2023)

Round Type

Seed

OakdaleManufacturingHealthcare

Quick answer

InSitu Biologics raised $3 Million in a Seed round, dated December 15, 2023. InSitu Biologics is based in Oakdale, Minnesota, United States.

How much did InSitu Biologics raise?
InSitu Biologics raised $3 Million in a Seed round on December 15, 2023.
What does InSitu Biologics do?
InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection.
Where is InSitu Biologics based and how big is it?
InSitu Biologics is based in Oakdale, Minnesota, United States. Fundz records about 8 employees.
Who are the decision-makers at InSitu Biologics?
Fundz holds 1 contact at InSitu Biologics, including the Managing Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as InSitu Biologics that raised within 45 days of this round, from Fundz verified event records.

  • RedHill Biopharma Ltd raised $10M on January 25, 2024.
  • ROM Technologies raised $200K (Seed) on January 19, 2024.
  • ivWatch raised $14M on January 12, 2024.
  • Doc.com raised $300M (Funding Round) on January 11, 2024.
  • OnPoint Surgical raised $20 on January 8, 2024.
  • ViaLase raised $45M (Seed) on January 5, 2024.

Who to call at InSitu Biologics, and when

A new round usually means InSitu Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day InSitu Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InSitu Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InSitu Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InSitu Biologics

Location

3510 Hopkins Place N.

Oakdale, Minnesota, United States

About

InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. We use disruptive technology to address unmet needs in the pain management and drug delivery markets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InSitu Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsKevin B., Managing DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for InSitu Biologics's next move

See what Strategic adds

InSitu Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.